Metropolitan Life Insurance Company (MetLife)’s Vivid Seats SEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-204
Closed -$24.4K 1750
2024
Q1
$24.4K Buy
204
+126
+162% +$14.8K ﹤0.01% 1756
2023
Q4
$9.85K Hold
78
﹤0.01% 2184
2023
Q3
$10K Hold
78
﹤0.01% 2209
2023
Q2
$12.3K Hold
78
﹤0.01% 2187
2023
Q1
$11.9K Sell
78
-10
-11% -$1.56K ﹤0.01% 2093
2022
Q4
$12.8K Hold
88
﹤0.01% 2203
2022
Q3
$13.5K Hold
88
﹤0.01% 2202
2022
Q2
$13.1K Buy
+88
New +$15.9K ﹤0.01% 2243

Other funds holding SEAT

Metropolitan Life Insurance Company (MetLife)'s SEAT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vivid Seats (SEAT) in Q2 2024, closing a stake of 204 shares — an estimated $24.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SEAT in Q2 2022 and held it in 8 quarters. The position peaked at $24.4K in Q1 2024. 128 funds tracked by Wall St. Rank hold SEAT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vivid Seats position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 204 Vivid Seats shares in Q2 2024, an estimated $24.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vivid Seats in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vivid Seats position peaked at $24.4K in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Vivid Seats as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.